Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet 25μg / 50μg in Treatment for Male Nocturia Due to Nocturnal Polyuria

NCT04329975 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT04329975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04329975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet 25μg / 50μg in Treatment for Male Nocturia Due to Nocturnal Polyuria
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
May 19, 2020
Completion date
September 25, 2024
Enrollment
1,087 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nocturia due to nocturnal polyuria